ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma

ClinicalTrials.gov ID: NCT04996004

Public ClinicalTrials.gov record NCT04996004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Study of TTI-621 in Combination With Doxorubicin in Patients With Unresectable or Metastatic High-Grade Leiomyosarcoma

Study identification

NCT ID
NCT04996004
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
76 participants

Conditions and interventions

Conditions

Interventions

  • Doxorubicin Drug
  • Ontorpacept (TTI-621) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 21, 2021
Primary completion
Dec 6, 2023
Completion
Dec 6, 2023
Last update posted
Dec 10, 2024

2021 – 2023

United States locations

U.S. sites
23
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Sarcoma Oncology Research Center Santa Monica California 90403
Mayo Clinic Florida Jacksonville Florida 32224
Moffitt Cancer Center Tampa Florida 33612
University of Iowa Hospital and Clinics Iowa City Iowa 52242
University of Michigan Ann Arbor Michigan 48109
MSK Basking Ridge. Basking Ridge New Jersey 07920
Hackensack University Medical Center Hackensack New Jersey 07601
MSK Monmouth Middletown New Jersey 07748
MSK Bergen Montvale New Jersey 07645
MSK Commack. Commack New York 11725
MSK Westchester Harrison New York 10604
Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy Long Island City New York 11101
Memorial Sloan Kettering Cancer Center 53rd street. New York New York 10022
Memorial Sloan Kettering Cancer Center - Main Campus New York New York 10065
Memorial Sloan Kettering Cancer Center 53rd street. New York New York 10065
MSK Nassau Uniondale New York 11553
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Oregon Health & Science University (OHSU) Portland Oregon 97239
Oregon Health and Science University - Center for Health and Healing 1 (CHH1) Portland Oregon 97239
Oregon Health and Science University - Center for Health and Healing 2(CHH2) Portland Oregon 97239
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232
Virginia Cancer Specialists Fairfax Virginia 22031
University of Wisconsin Clinical Science Center Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04996004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 10, 2024 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04996004 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →